medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2006, Number 6

<< Back Next >>

Rev Mex Urol 2006; 66 (6)

Evolution of the radical nephrectomy versus preserving surgery of nephrons in the renal cells carcinoma

Farfán CFA, Silva IP, Matos LE, García GA, Bautista MJ

Language: Spanish
References: 19
Page: 277-282
PDF size: 105.93 Kb.


ABSTRACT

Antecedents. The radical nefrectomy (NR) it is the reference in the healing treatment of the carcinoma of renal cells (CCR) located, however the conservative surgery (CPN) this winning bigger followers.
Objectives. We realize sectional cross study to compare the evolution of the NR with the CPN in the CCR T1N0M0.
Material and Method. Period of January of 2000 to December of 2005.
Inclusion approaches. NR: T1 that affects the excretor system. CPN: Optional, T1aN0M0 Advisable genetic illnesses. Forced, monorrenos and bilateral tumor.
Results. 20 NR and 12 CPN were carried out with having been histology of clear cells 17-10. papilar 1-0. Cromófobo 2-0 and Oncocitoma 0-2, nuclear grade Fuhrman I of 10-8 and II of 7-2 for NR and CPN respectively. Age average 54.5 years. But it frequents right side and of central localization. Half size of 5.8 cm in NR and 3.3 cm for CPN. There were not complications. Surgical time NR of 2 hours 20 minutes and in CPN 2 hours 40 minutes. The hospital demurrage of 5 days with a survival free of illness for 5 years of 100%.
Discussion. The precocious diagnosis determinesthat the surgery is the healing treatment of election, the size it is controversial in the CPN, the histological type is a factor presage.
Conclusions. As much the NR as the CPN have a survival from 100% free of illness to the 5 years, settling down this last one as the reference option.


REFERENCES

  1. Walsh Patrick C, Retik Alan B, Vaughan Darracott, Wein Alan J. Tumores renales Campbell Urología. Tomo 4, 8va Edición. Ed. Médica Panamericana. 2005; 2911-2979.

  2. Dhote R, Thiounn N, Debré B, Vidal-Trecan G. Risk factors for adult renal cell carcinoma. Urol Clin N Am. 2004;31:237-247.

  3. Uzzo RG, Cairns P, Al-Saleem T, Hudes G, Haas N, Greenberg HE, Kolenko V. The basic biology and immunobiology of renal cell carcinoma: considerations for the clinician. Urol Clin N Am. 2003;30:423-436.

  4. Pavlovich ChP, Schmidt LS, Phillips JL. The genetic basis of renal cell carcinoma. Urol Clin N Am. 2003; 30:437-454.

  5. Maranchie JK, Marston Linehan W. Genetic disorders and renal cell carcinoma. Urol Clin N Am. 2003;30: 133-141.

  6. Kontak JA, Campbell SC. Prognostic factors in renal cell carcinoma. Urol Clin N Am. 2003;30:467-480.

  7. Mulders P, Bleumer I, Oosterwijk E. Tumor antigens and markers in renal cell carcinoma. Urol Clin N Am. 2003;30:455-465.

  8. Israel GM, Bosniak MA. Renal imaging for diagnosis and staging of renal cell carcinoma. Urol Clin N Am. 2003;30:499-514.

  9. Nieder AM, Taneja SS. The role of partial nephrectomy for renal cell carcinoma in contemporary practice. Urol Clin N Am. 2003;30:529-542.

  10. Managadze PA. Long-term results of nephron-sparing surgery for small renal tumors with elective indications. Georgian Med News. 2006;(135):12-6.

  11. Walsh Patrick C, Retik Alan B, Vaughan Darracott, Wein Alan J. Cirugía Renal. Nefrectomia parcial en enfermedad maligna. Campbell Urología. Tomo 4, 8va Edición. Ed. Médica Panamericana. 2005; 3951-3963.

  12. Osorio V. Cirugía conservadora en pacientes con tumores sólidos del riñón: fundamentos y resultados. Urol Pan. 1999;II:15 1999.

  13. Pedro Silva I, Farfán Chavez F, Osorio Acosta V, Garcia Garcia A, Matos Lobaina E, De la Cruz Alvarez M, Cuendias Abreu B. Cirugía conservadora en tumores sólidos de riñón. Rev Mex Urol. 2006;66:69-73.

  14. Lapini A, Serni S, Minervini A, Masieri L, Carini M. Progression and long-term survival after simple enucleation for the elective treatment of renal cell carcinoma: experience in 107 patients. J Urol. 2005;174:57-60.

  15. Matin SF, Gill IS, Worley S, Novick AC. Outcome of laparoscopic radical and open partial nephrectomy for the sporadic 4 cm. or less renal tumor with a normal contralateral kidney. J Urol. 2002;168(4 Pt 1): 1356-9; discussion 1359-60.

  16. Roupret M, Hopirtean V, Mejean A, Thiounn N, Dufour B, Chretien Y, Chauveau D, Richard S. Nephron sparing surgery for renal cell carcinoma and von Hippel- Lindau’s disease: a single center experience. J Urol. 2003;170:1752-5.

  17. Minowada S, Homma Y, Takeuchi T, Tomita K, Kameyama S, Ohta N, Kitamura T. Surgical outcomes of nephron-sparing surgery for renal tumors. Nippon Hinyokika Gakkai Zasshi. 2002;93:555-61.

  18. Carini M, Minervini A, Masieri L, Lapini A, Serni S. Simple. Enucleation for the Treatment of PT1a Renal Cell Carcinoma: Our 20-Year Experience. Eur Urol. 2006;50:1263-71.

  19. Carini M, Minervini A, Lapini A, Masieri L, Serni S. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival. J Urol. 2006; 175:2022-6.




2020     |     www.medigraphic.com